HEADER TRANSFERASE 11-JUL-19 6S90 TITLE BTK IN COMPLEX WITH AN INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE,ATK,B-CELL PROGENITOR COMPND 5 KINASE,BPK,BRUTON TYROSINE KINASE; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS BTK, BRUTON TYROSINE KINASE, AGAMMAGLOBULINAEMIA TYROSINE KINASE, KEYWDS 2 ATK, B-CELL PROGENITOR KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.GUTMANN,A.HINNIGER REVDAT 3 15-MAY-24 6S90 1 REMARK REVDAT 2 30-OCT-19 6S90 1 JRNL REVDAT 1 18-SEP-19 6S90 0 JRNL AUTH R.PULZ,D.ANGST,J.DAWSON,F.GESSIER,S.GUTMANN,R.HERSPERGER, JRNL AUTH 2 A.HINNIGER,P.JANSER,G.KOCH,L.REVESZ,A.VULPETTI,R.WAELCHLI, JRNL AUTH 3 A.ZIMMERLIN,B.CENNI JRNL TITL DESIGN OF POTENT AND SELECTIVE COVALENT INHIBITORS OF JRNL TITL 2 BRUTON'S TYROSINE KINASE TARGETING AN INACTIVE CONFORMATION. JRNL REF ACS MED.CHEM.LETT. V. 10 1467 2019 JRNL REFN ISSN 1948-5875 JRNL PMID 31620235 JRNL DOI 10.1021/ACSMEDCHEMLETT.9B00317 REMARK 2 REMARK 2 RESOLUTION. 1.82 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.04 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 46198 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.201 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.920 REMARK 3 FREE R VALUE TEST SET COUNT : 2274 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.84 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 83.12 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 924 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2161 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 884 REMARK 3 BIN R VALUE (WORKING SET) : 0.2150 REMARK 3 BIN FREE R VALUE : 0.2383 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.33 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 40 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4157 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 467 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.92500 REMARK 3 B22 (A**2) : -2.54220 REMARK 3 B33 (A**2) : 1.61710 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.06480 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.190 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.134 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.120 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.126 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.117 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.922 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4354 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5900 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1497 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 794 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4354 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 542 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5492 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.97 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.62 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.69 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 18.9116 -17.4739 1.6939 REMARK 3 T TENSOR REMARK 3 T11: -0.0269 T22: -0.0325 REMARK 3 T33: -0.0228 T12: -0.0003 REMARK 3 T13: 0.0063 T23: -0.0016 REMARK 3 L TENSOR REMARK 3 L11: 0.4533 L22: 0.5060 REMARK 3 L33: 1.2057 L12: 0.0774 REMARK 3 L13: 0.0563 L23: 0.0516 REMARK 3 S TENSOR REMARK 3 S11: -0.0188 S12: 0.0103 S13: 0.0168 REMARK 3 S21: 0.0181 S22: -0.0081 S23: 0.0047 REMARK 3 S31: 0.0544 S32: -0.0286 S33: 0.0269 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 0.9685 -4.9607 44.0999 REMARK 3 T TENSOR REMARK 3 T11: -0.0347 T22: -0.0201 REMARK 3 T33: -0.0081 T12: -0.0044 REMARK 3 T13: -0.0109 T23: 0.0090 REMARK 3 L TENSOR REMARK 3 L11: 0.6544 L22: 0.2836 REMARK 3 L33: 0.6867 L12: -0.0503 REMARK 3 L13: -0.1976 L23: -0.0032 REMARK 3 S TENSOR REMARK 3 S11: 0.0181 S12: 0.0024 S13: -0.0039 REMARK 3 S21: -0.0155 S22: -0.0088 S23: 0.0127 REMARK 3 S31: -0.0158 S32: -0.0377 S33: -0.0093 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6S90 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-JUL-19. REMARK 100 THE DEPOSITION ID IS D_1292103297. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.999900 REMARK 200 MONOCHROMATOR : SI(III) MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46201 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.820 REMARK 200 RESOLUTION RANGE LOW (A) : 64.960 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.04400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.82 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.83 REMARK 200 COMPLETENESS FOR SHELL (%) : 68.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS-HCL PH 8.5, 200 MM SODIUM REMARK 280 FORMATE, 50 MM CACL2, 25% (W/V) PEGMME 5000, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 67.91500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.68000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 67.91500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.68000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 393 REMARK 465 SER A 394 REMARK 465 GLU A 657 REMARK 465 GLU A 658 REMARK 465 GLY B 393 REMARK 465 SER B 394 REMARK 465 GLU B 657 REMARK 465 GLU B 658 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TRP A 395 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 395 CZ3 CH2 REMARK 470 GLN A 424 CG CD OE1 NE2 REMARK 470 TYR A 425 CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU A 441 CG CD OE1 OE2 REMARK 470 GLU A 444 CG CD OE1 OE2 REMARK 470 LYS A 447 CG CD CE NZ REMARK 470 GLU A 455 CG CD OE1 OE2 REMARK 470 LYS A 466 CG CD CE NZ REMARK 470 GLN A 496 CG CD OE1 NE2 REMARK 470 GLU A 550 CG CD OE1 OE2 REMARK 470 VAL A 555 CG1 CG2 REMARK 470 MET A 570 CG SD CE REMARK 470 LYS A 573 CG CD CE NZ REMARK 470 GLU A 599 CG CD OE1 OE2 REMARK 470 ARG A 600 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 608 CG CD OE1 OE2 REMARK 470 GLN A 612 CG CD OE1 NE2 REMARK 470 LEU A 614 CG CD1 CD2 REMARK 470 LYS A 625 CG CD CE NZ REMARK 470 GLU A 636 CG CD OE1 OE2 REMARK 470 LYS A 637 CG CD CE NZ REMARK 470 GLU A 640 CG CD OE1 OE2 REMARK 470 MET A 655 CE REMARK 470 ASP A 656 CG OD1 OD2 REMARK 470 GLU B 434 CG CD OE1 OE2 REMARK 470 GLU B 455 CG CD OE1 OE2 REMARK 470 GLU B 488 CG CD OE1 OE2 REMARK 470 GLN B 496 CG CD OE1 NE2 REMARK 470 LYS B 595 CG CD CE NZ REMARK 470 GLU B 599 CG CD OE1 OE2 REMARK 470 ARG B 600 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 624 CG CD OE1 OE2 REMARK 470 LYS B 625 CG CD CE NZ REMARK 470 GLU B 636 CG CD OE1 OE2 REMARK 470 LYS B 637 CG CD CE NZ REMARK 470 GLU B 640 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 424 -44.83 -148.18 REMARK 500 ARG A 520 -15.84 82.17 REMARK 500 ASP A 521 49.82 -143.85 REMARK 500 ASP A 548 105.32 -179.06 REMARK 500 GLN B 424 -45.85 -146.66 REMARK 500 LYS B 466 47.23 -88.73 REMARK 500 ARG B 520 -14.11 83.12 REMARK 500 ASP B 521 49.75 -146.62 REMARK 500 ASP B 548 106.20 -179.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue L0Z A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue L0Z B 701 DBREF 6S90 A 393 658 UNP Q06187 BTK_HUMAN 393 658 DBREF 6S90 B 393 658 UNP Q06187 BTK_HUMAN 393 658 SEQRES 1 A 266 GLY SER TRP GLU ILE ASP PRO LYS ASP LEU THR PHE LEU SEQRES 2 A 266 LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL LYS TYR SEQRES 3 A 266 GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS MET SEQRES 4 A 266 ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE ILE GLU SEQRES 5 A 266 GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU LYS LEU SEQRES 6 A 266 VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG PRO ILE SEQRES 7 A 266 PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS LEU LEU SEQRES 8 A 266 ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN THR GLN SEQRES 9 A 266 GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU ALA MET SEQRES 10 A 266 GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG ASP LEU SEQRES 11 A 266 ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL VAL SEQRES 12 A 266 LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL LEU ASP SEQRES 13 A 266 ASP GLU TYR THR SER SER VAL GLY SER LYS PHE PRO VAL SEQRES 14 A 266 ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER LYS PHE SEQRES 15 A 266 SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL LEU MET SEQRES 16 A 266 TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR GLU ARG SEQRES 17 A 266 PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA GLN GLY SEQRES 18 A 266 LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU LYS VAL SEQRES 19 A 266 TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS ALA ASP SEQRES 20 A 266 GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN ILE LEU SEQRES 21 A 266 ASP VAL MET ASP GLU GLU SEQRES 1 B 266 GLY SER TRP GLU ILE ASP PRO LYS ASP LEU THR PHE LEU SEQRES 2 B 266 LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL LYS TYR SEQRES 3 B 266 GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS MET SEQRES 4 B 266 ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE ILE GLU SEQRES 5 B 266 GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU LYS LEU SEQRES 6 B 266 VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG PRO ILE SEQRES 7 B 266 PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS LEU LEU SEQRES 8 B 266 ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN THR GLN SEQRES 9 B 266 GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU ALA MET SEQRES 10 B 266 GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG ASP LEU SEQRES 11 B 266 ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL VAL SEQRES 12 B 266 LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL LEU ASP SEQRES 13 B 266 ASP GLU TYR THR SER SER VAL GLY SER LYS PHE PRO VAL SEQRES 14 B 266 ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER LYS PHE SEQRES 15 B 266 SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL LEU MET SEQRES 16 B 266 TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR GLU ARG SEQRES 17 B 266 PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA GLN GLY SEQRES 18 B 266 LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU LYS VAL SEQRES 19 B 266 TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS ALA ASP SEQRES 20 B 266 GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN ILE LEU SEQRES 21 B 266 ASP VAL MET ASP GLU GLU HET L0Z A 701 44 HET L0Z B 701 44 HETNAM L0Z 4-~{TERT}-BUTYL-~{N}-[2-METHYL-3-[6-[4-(4- HETNAM 2 L0Z METHYLPIPERAZIN-1-YL)CARBONYLPHENYL]-7~{H}-PYRROLO[2, HETNAM 3 L0Z 3-D]PYRIMIDIN-4-YL]PHENYL]BENZAMIDE FORMUL 3 L0Z 2(C36 H38 N6 O2) FORMUL 5 HOH *467(H2 O) HELIX 1 AA1 ASP A 398 LYS A 400 5 3 HELIX 2 AA2 SER A 438 ASN A 451 1 14 HELIX 3 AA3 CYS A 481 MET A 489 1 9 HELIX 4 AA4 GLN A 494 LYS A 515 1 22 HELIX 5 AA5 ALA A 523 ARG A 525 5 3 HELIX 6 AA6 GLY A 541 VAL A 546 5 6 HELIX 7 AA7 ASP A 548 SER A 553 1 6 HELIX 8 AA8 PRO A 560 SER A 564 5 5 HELIX 9 AA9 PRO A 565 SER A 572 1 8 HELIX 10 AB1 SER A 575 SER A 592 1 18 HELIX 11 AB2 THR A 602 GLN A 612 1 11 HELIX 12 AB3 SER A 623 CYS A 633 1 11 HELIX 13 AB4 LYS A 637 ARG A 641 5 5 HELIX 14 AB5 THR A 643 ASP A 656 1 14 HELIX 15 AB6 ASP B 398 LYS B 400 5 3 HELIX 16 AB7 SER B 438 ASN B 451 1 14 HELIX 17 AB8 CYS B 481 MET B 489 1 9 HELIX 18 AB9 GLN B 494 LYS B 515 1 22 HELIX 19 AC1 ALA B 523 ARG B 525 5 3 HELIX 20 AC2 GLY B 541 VAL B 546 5 6 HELIX 21 AC3 ASP B 548 SER B 553 1 6 HELIX 22 AC4 PRO B 560 SER B 564 5 5 HELIX 23 AC5 PRO B 565 SER B 572 1 8 HELIX 24 AC6 SER B 575 SER B 592 1 18 HELIX 25 AC7 THR B 602 ALA B 611 1 10 HELIX 26 AC8 SER B 623 CYS B 633 1 11 HELIX 27 AC9 LYS B 637 ARG B 641 5 5 HELIX 28 AD1 THR B 643 ASP B 656 1 14 SHEET 1 AA1 5 LEU A 402 GLY A 411 0 SHEET 2 AA1 5 GLY A 414 TRP A 421 -1 O TYR A 418 N LEU A 405 SHEET 3 AA1 5 TYR A 425 MET A 431 -1 O ILE A 429 N LYS A 417 SHEET 4 AA1 5 PHE A 471 GLU A 475 -1 O ILE A 472 N LYS A 430 SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N GLY A 462 O ILE A 473 SHEET 1 AA2 2 CYS A 527 VAL A 529 0 SHEET 2 AA2 2 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 SHEET 1 AA3 5 LEU B 402 GLY B 411 0 SHEET 2 AA3 5 GLY B 414 TRP B 421 -1 O TYR B 418 N LYS B 406 SHEET 3 AA3 5 TYR B 425 MET B 431 -1 O ILE B 429 N LYS B 417 SHEET 4 AA3 5 PHE B 471 THR B 474 -1 O ILE B 472 N LYS B 430 SHEET 5 AA3 5 LEU B 460 CYS B 464 -1 N GLY B 462 O ILE B 473 SHEET 1 AA4 2 CYS B 527 VAL B 529 0 SHEET 2 AA4 2 VAL B 535 VAL B 537 -1 O LYS B 536 N LEU B 528 CISPEP 1 ARG A 468 PRO A 469 0 -3.59 CISPEP 2 ARG B 468 PRO B 469 0 -0.47 SITE 1 AC1 22 LEU A 408 PHE A 413 VAL A 416 ALA A 428 SITE 2 AC1 22 LYS A 430 GLU A 475 TYR A 476 MET A 477 SITE 3 AC1 22 ALA A 478 ASN A 479 GLY A 480 GLU A 488 SITE 4 AC1 22 ARG A 490 ASP A 521 ASN A 526 SER A 538 SITE 5 AC1 22 ASP A 539 VAL A 546 TYR A 551 HOH A 844 SITE 6 AC1 22 HOH A 904 HOH A 943 SITE 1 AC2 20 LYS B 406 PHE B 413 VAL B 416 TYR B 418 SITE 2 AC2 20 ALA B 428 LYS B 430 GLU B 475 TYR B 476 SITE 3 AC2 20 MET B 477 ALA B 478 ASN B 479 GLY B 480 SITE 4 AC2 20 ASP B 521 ASN B 526 ASP B 539 VAL B 546 SITE 5 AC2 20 TYR B 551 HOH B 888 HOH B 960 HOH B 975 CRYST1 135.830 39.360 105.190 90.00 111.18 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007362 0.000000 0.002853 0.00000 SCALE2 0.000000 0.025407 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010195 0.00000